Compare · 3 funds side by side · dividends reinvested

IDNA, XLV and VOO

Story of the three · Growth5Y$10,000 five years agoDividends reinvested · all three on one scale$17,749VOO · best of the three

02 / 04

IDNA, XLV and VOO, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Vanguard S&P 500 ETFLow-Cost Core · S&P 5000.03%1.07%+11.5%+11.9%+24.1%+12.2%−8.9%12.7%$1.00T1.8

State Street Health Care Select Sector SPDR ETFSectors · Health care0.08%1.39%+20.4%+29.7%+16.2%+8.5%−10.5%16.4%$49.1B2.0

iShares Genomics Immunology and Healthcare ETFSectors · Health care0.47%0.66%+62.8%+69.2%+36.3%−2.2%−10.6%29.7%$340M2.3

Rank among the three1st → 3rdFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 3, 2026 · returns include dividends · since: IDNA 2019 · XLV 1998 · VOO 2010

Head to Head

Swap sides Versus in desk

Head to Head

iShares Genomics Immunology and Healthcare ETF · $340M$8,934

IDNA

XLV

State Street Health Care Select Sector SPDR ETF · $49.1B$15,068

$10,000 five years ago, dividends reinvested · they hold 8.2% in common

IDNAMeasureXLV

+62.8%Year to dateJan 1 → Nov 3+20.4%

+69.2%1 yearTotal return+29.7%

+36.3%3 years · per year$10,000 became $25,310 · $15,709+16.2%

−2.2%5 years · per year$10,000 became $8,934 · $15,068+8.5%

0.47%Expense ratio$47 · $8 a year on $10k · lower is better0.08%

0.66%Trailing 12-mo yield$66 · $139 a year on $10k1.39%

−10.6%Worst dropSmaller is better−10.5%

29.7%VolatilityLower is calmer16.4%

IDNAXLV Winner of the row, in its colourEach row: the bigger of the two fills its side

3–5XLV wins

End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

IDNA vs XLV: Top 5 Holdings

Today

IDNA

33.2%in top 5

XLV

in top 545.0%

IDNAStockXLV

not top 5LLY16.5%

12.8%MRNAnot top 5

not top 5JNJ9.9%

not top 5ABBV7.7%

6.5%GMAB.COnot top 5

6.1%TWSTnot top 5

not top 5UNH5.5%

not top 5MRK5.4%

4.0%REGNnot top 5

3.8%4502.Tnot top 5

Held in common8.2%

End-of-day Nov 3, 2026 · share of each fund

IDNA vs XLV Returns, Every Period

iSharesIDNA

−2.2%

5 years, per year

XLVSPDR

+8.5%

5 years, per year

IDNAXLVFaded: behind in that period

3–1IDNA wins

End-of-day Nov 3, 2026 · dividends in · faded = behind in that period

IDNA vs XLV

YTD

iSharesIDNA

+62.8%

XLVSPDR

+20.4%

+62.8%Year to date+20.4%

−10.6%Worst drop · 1Y−10.5%

29.7%Volatility · 1Y16.4%

0.7%Yield1.4%

$340MAssets$49.1B

3–1XLV wins

End-of-day Nov 3, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: IDNA, XLV, VOO

Today

0.03%lowest, VOO

FundExpense ratioFee$10k

VOO0.03%$3

XLV0.08%$8

IDNA0.47%$47

End-of-day Nov 3, 2026 · fee on $10,000 a year

Yields: IDNA, XLV, VOO

1.39%highest, XLV

FundTrailing yieldYield$10k

XLV1.39%$139

VOO1.07%$107

IDNA0.66%$66

End-of-day Nov 3, 2026 · trailing 12-month yield

Income After Fees on $10,000

$131most kept, XLV

XLV$139 − $8 = $131

VOO$107 − $3 = $104

IDNA$66 − $47 = $19

KeptFee

End-of-day Nov 3, 2026 · yield in dollars minus the fee

Overlap: IDNA, XLV, VOO

Today

9.3%most shared, XLV and VOO

IDNAXLVVOO

IDNA—8.2%1.0%

XLV8.2%—9.3%

VOO1.0%9.3%—

End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 3 ETFs

+69.2%IDNA, at 29.7% volatility

VOOWorst drop−8.9%12.7% vol

XLVWorst drop−10.5%16.4% vol

IDNAWorst drop−10.6%29.7% vol

End-of-day Nov 3, 2026 · up and left is better

Paid More vs Made More

YTD

XLVIDNA

+20.4%Year to date+62.8%

1.4%Yield0.7%

+29.7%Past year+69.2%

0.08%Fee0.47%

2–2level

End-of-day Nov 3, 2026

Popular Pairs Near These Three

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

+11.5%Year to date+11.5%

1.0%Yield1.0%

$185BAssets$798B

0–0level

End-of-day Nov 3, 2026

VOO vs IVV

YTD

VanguardVOO

+11.5%

IVViShares

+11.6%

+11.5%Year to date+11.6%

1.1%Yield1.1%

$1.00TAssets$872B

1–0IVV wins

End-of-day Nov 3, 2026

SCHD vs VIG

YTD

SchwabSCHD

+32.8%

VIGVanguard

+14.0%

+32.8%Year to date+14.0%

3.0%Yield1.5%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 3, 2026